Home > News > Q10: Stuart Hendry, CEO at Sphere Medical
September 5th, 2007
Q10: Stuart Hendry, CEO at Sphere Medical
Abstract:
Sphere, which was founded in 2002, is combining its patented microtechnology and nanotechnology to develop unique dice-sized microanalysers capable of measuring several key compounds such as, glucose, blood gases and drugs, simultaneously at low cost. Mortality in critical care remains unacceptably high, with associated costs of £billions annually. Real time measurement of drugs and physiological parameters, facilitating tight control of therapy, has been shown to dramatically improve patient outcomes, saving lives and money. Unfortunately, cost effective products to achieve this ideal are not currently available.
Source:
businessweekly.co.uk
Bookmark:
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
Simple algorithm paired with standard imaging tool could predict failure in lithium metal batteries August 8th, 2025
First real-time observation of two-dimensional melting process: Researchers at Mainz University unveil new insights into magnetic vortex structures August 8th, 2025
Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||